Affiliation:
1. Division of Thoracic Surgery, The Thoracic Surgery Oncology Laboratory and the International Mesothelioma Program, Lung Center Brigham and Women's Hospital, and Harvard Medical School Boston Massachusetts USA
Abstract
AbstractThe surgical management of pleural mesothelioma (PM) can be divided into diagnostic, staging, palliation, and cytoreductive surgery. In the cytoreductive surgical setting, the combination of different treatment modalities has led to better outcomes than surgery alone. The scarcity of high‐quality studies has led to heterogeneity in management of PM across the mesothelioma treatment centers. Here, we review the literature regarding the most important open questions and ongoing clinical trials.
Subject
Oncology,General Medicine,Surgery
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献